A recent study demonstrates a tool to help physicians better diagnose the cause of fevers in children.
Ill child in the hospital (Adobe Stock)
Classifying bacterial from viral causes of a patient’s fever in the emergency department (ED) in order to give proper care is crucial, considering antibacterial resistance is on the rise, the patient’s health could deteriorate, and time restraints of care in the ED.
In a recent study, to distinguish bacterial from viral infections, a host-protein score (BV) which combined the circulating levels of TNF-related apoptosis-induced ligand (TRAIL), interferon-γ-induced protein-10 (IP-10), and C-reactive protein (CRP), which can accurately differentiate bacterial from viral infections, was investigated. Comparing the BV to physician’s etiological diagnosis, the investigators evaluated the BV’s potential to impact decision-making in the ED.
The study, “Bacterial vs viral etiology of fever: a prospective study to estimate a host score’s potential to support ED physicians' etiologic accuracy,” was presented as a poster by Meirav Mor, MD, Head of hospital infection control and epidemiology and attending ED physician Schneider Children's Medical Center of Israel; Tel Aviv University Petach Tikva, Israel, at the IDWeek Conference in Washington, DC, on October 19-23, 2022.
“Overall, BV could potentially correct physician diagnosis and reduce error greater than 2-fold, from 16.1% to 8.1%.” the Mor, et al, noted on the poster.
The study demonstrated that a BV could conceivably assist the diagnostic process. However, the investigators noted that further studies are warranted to evaluate the practical effect of BV in the ED.
The study’s participants had a febrile respiratory tract infection or a fever without source, and they ranged from 3 months to 18 years, and were recruited from a tertiary care pediatric ED.Symptoms for fewer than 7 days and immunocompetence were the main eligibility criteria. Reasons for not qualifying were having antibiotics longer than the previous 48 hours, having a fever below the threshold, and a recent episode of infection. The “ED physician’s initial etiological suspicion (bacterial/viral/I don’t know) and degree of confidence (low/medium/high) were recorded in a questionnaire.”
Then the investigators interpreted the BV based on pre-defined score thresholds (viral/bacterial/equivocal).” To make the study clearer, the physician was unable to access the results. The reference standard for etiology was based on the diagnoses (bacterial/viral/indeterminate) of 3 independent pediatricians who were provided with all available patient data but not allowed to see the BV.
The investigators wrote, “BV’s potential to impact the physician’s etiologic accuracy was estimated according to alignment between BV and etiological suspicion as filled in the questionnaire (assuming full adoption of BV by the physician).”
Only 290 out of the 348 patients recruited, met eligibility criteria and had the necessary serum sample. The patients’ median age was 1.3 years (interquartile range 1.7), and 37.5% were female. Only 211 patients had questionnaires filled out. The physician’s label and reference standard matched the BV in 72% of the cases (151/211). However, only, 52% (78/151) of these were marked by the physician with low/medium confidence. In these cases, the BV could reinforce the physician’s proposal. Only 12% of the cases (26/211) demonstrated that the BV aligned with the reference standard but not with the physician’s suspicion, and, therefore, could correct the physician's bacterial vs viral diagnosis. Interestingly, the “BV did not align with the reference standard in 7% of the cases (14/211) and was equivocal in 9% of the cases (20/211),” the investigators noted.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.